• Services
    • Custom Research & Development
      • Nucleic Acid
        • siRNA In Vitro Screening Service
        • One-Stop Antisense Oligonucleotide (ASO) Development
        • Circular RNAs (circRNAs) Services
      • Viral Vector
        • Adeno-associated Virus Vector
        • Adenoviral Vector Development Service
        • Lentiviral Vector Development Service
        • Herpes Simplex Virus Vector Development Service
        • Vaccinia Viral Vector Development Service
        • Baculovirus Vector
        • Other Viral Vectors
    • Custom Production
      • Viral Vector
      • Nucleic Acid
    • Custom Formulation & Conjugation
      • Lipid Nanoparticle (LNP)
        • Mitochondrial Targeting LNP
      • Antibody-siRNA Conjugates (ARCs)
      • Antibody-Oligo Conjugates (AOCs)
      • N-Acetylgalactosamine (GalNAc)
      • Others
        • Development of Polyplexes as Gene Delivery System
        • Development of Dendrimers as Gene Delivery System
        • Development of Stem Cells as Gene Delivery System
        • Development of Dendritic Cell as Gene Delivery System
        • Development of Bacteria as Gene Delivery System
        • Custom Aptamer Screening
        • Custom Nanoparticles Service
        • Custom Polymers Service
        • Custom Nucleic Acid Nanostructure Service
        • Custom Exosomes Service
    • GTOnco™ Immuno-Oncology Assay Services
      • GTOnco™ I-O Assays for In Vitro Study
      • GTOnco™ I-O Assays for In Vivo Study
    • Analytical Testing & Quality Control
      • Nucleic Acid Anaylsis
        • Identity of Nucleic Acid
        • Concentration of Nucleic Acid
        • Safety of Nucleic Acid
        • Potency of Nucleic Acid
        • Purity of Nucleic Acid
      • Viral Vector Analysis
        • Identity of Viral Vector
        • Titer of Viral Vector
        • Safety of Viral Vector
        • Potency of Viral Vector
        • Purity of Viral Vector
      • Other Service
        • Mitochondrial Toxicity Assay
        • RNA Profiling Service
    • CRISPR assisted Gene Editing Solutions
      • CRISPR assisted Cell Line Development
        • Gene Knockout
        • Gene Knock-in
        • Point Mutation
        • Cas9 Overexpressing Cell Line Development
        • dCas9-VPH Overexpressing Cell Line Development
        • dCas9-VPR Overexpressing Cell Line Development
        • dCas9-KRAB Overexpressing Cell Line Development
      • CRISPR based Screening Solutions
        • Genome-Wide CRISPR Screening
        • CRISPRa Screening
        • CRISPRi Screening
        • Single-Cell CRISPR Screening
        • Custom CRISPR Screening
      • CRISPR related Delivery Agent Construction
        • Lipid Nanoparticle (LNP) Formulation through CRISPR
        • Viral Vector Construction through CRISPR
        • gRNA Cloning through CRISPR
        • Gene Editing Donor Vector Construction through CRISPR
      • Disease Modeling related Gene Editing
      • Library Design through CRISPR
      • Nuclease Activity Measurement
  • Products
    • Antisense Oligonucleotides (ASOs)
      • Cancer
      • Cytomegalovirus Retinitis
      • Familial Hypercholesterolemia
      • Viral Hemorrhagic Fever
      • HIV/AIDS
      • Spinal Muscular Atrophy
      • Duchenne Muscular Dystrophy
      • Hypertriglyceridemia
      • ASO Others
    • Recombinant Virus
      • Recombinant Adeno-Associated Virus
      • Recombinant Adenovirus
      • Recombinant Lentivirus
      • Recombinant Retrovirus
    • SARS-CoV-2 Research
      • Pseudovirus
      • Overexpressing Virus
    • Small Interfering RNA (siRNA)
    • Circular RNAs (circRNAs) Products
      • Reporter Circular RNA Products
  • Platforms
    • GTOnco™ Platform for Gene Therapy-based I-O Drug Development
  • Therapeutic Areas
    • Gene Therapy Development for Diseases
      • Gene Therapy Development for Genetic Disorders
      • Gene Therapy Development for Acquired Diseases
  • Resources
    • Support Knowledge
      • In Vivo Cell Therapy: Advancing Precision Medicine Through Direct Cellular Interventions
      • Application of gene therapy in cancer treatment- From theory to preclinical research
      • Application of Adeno-associated Viral Vectors in the Central Nervous System
      • Therapeutic Nucleic Acids
      • Approaches to Genome Editing
      • Strategies for Gene Delivery
      • Gene Therapy in Clinical Trials
      • Genes and Associated Diseases
      • Gene Therapy for Human Genetic Disorders
      • Strategies for Circular RNA Synthesis
    • Podcasts
    • Webinars
      • Programmable Molecular Tools for Biology and Genome EditingHot
      • Development of Gene Therapy for Genetic Hearing Loss
      • Optimal Therapeutic Intervention Timepoints for siRNA-Based Huntington's Disease Therapies
  • About Us
  • Careers
  • Contact Us
  • Inquiry
  • Company
    • About Us
    • Careers
    • Contact Us
    • Inquiry
Gene Therapy
  • Home
  • Products
  • Recombinant Virus
  • Recombinant Adeno-Associated Virus
  • AAV-CMV βGlobin (EGFP), NC(CAT#: AAV-GTXH019WQ)

AAV-CMV βGlobin (EGFP), NC(CAT#: AAV-GTXH019WQ)

Datasheet

The product is an adeno-associated virus vector that can be used as a negative control in the gene therapy reserch and development.

Specifications
Family Parvoviridae
Species Adeno-associated virus (AAV)
Serotype AAV2/8
Tropism Both nondividing and dividing cells
Titer >1.00E+12 v.g./mL
Reporter EGFP
Application Negative Control

Related Products

Recombinant adeno-associated virus type 9, pU6-(Human VEGF165), Overexpression (CAT#:AAV-GTOH1106WQ) shRNA Adeno-associated Virus Serotype 2, p7SK-(ENSMUSG00000063277-shRNA-Seq6) (CAT#:AAV-SI3900WQ) shRNA Adeno-associated Virus Serotype 2, pH1-(C12orf32-shRNA-Seq2) (CAT#:AAV-SI0900WQ) Recombinant adeno-associated virus type 2, pU6-(Mouse Timp2 3'UTR), Overexpression (CAT#:AAV-GTOH0577WQ) shRNA Adeno-associated Virus Serotype 2, pH1-(Nudcd1-shRNA-Seq1) (CAT#:AAV-SI2699WQ) AAV PHP.S-mRUNX2p (MCS-EGFP-3Flag)-SV40 PolyA (CAT#:AAV-GTK0683WQ) shRNA Adeno-associated Virus Serotype 2, p7SK-(SERINC5-shRNA-Seq1) (CAT#:AAV-SI1498WQ) shRNA Adeno-associated Virus Serotype 2, p7SK-(AARSD1-shRNA-Seq1) (CAT#:AAV-SI1345WQ)

    Products

    • Antisense Oligonucleotides (ASOs)+
      • Cancer
      • Cytomegalovirus Retinitis
      • Familial Hypercholesterolemia
      • Viral Hemorrhagic Fever
      • HIV/AIDS
      • Spinal Muscular Atrophy
      • Duchenne Muscular Dystrophy
      • Hypertriglyceridemia
      • ASO Others
    • Recombinant Virus-
      • Recombinant Adeno-Associated Virus
      • Recombinant Adenovirus
      • Recombinant Lentivirus
      • Recombinant Retrovirus
    • SARS-CoV-2 Research+
      • Pseudovirus
      • Overexpressing Virus
    • Small Interfering RNA (siRNA)
    • Circular RNAs (circRNAs) Products+
      • Reporter Circular RNA Products

Online Inquiry

For research use only. Not intended for any clinical use.
  • <
    May 2025
    >
    Sun Mon Tue Wed Thu Fri Sat
    10
    11121314151617
    18192021222324
    25262728293031
    -

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Services
  • Custom Nucleic Acid Production
  • Custom GalNAc-siRNA conjugation
  • Custom Viral Vector Development
  • siRNA In Vitro Screening
  • GTOnco™ Immuno-Oncology Assay Services
Products
  • Recombinant Virus
  • Antisense Oligonucleotides (ASOs)
  • Small Interfering RNA (siRNA)
  • SARS-CoV-2 Research
Contact Us
  • Tel:
  • Fax:
  • Global Locations
Enter your email here to subscribe.
Submit
    • Follow Us:
ISO 9001 Certified - Creative Biolabs Quality Management System.
Copyright © 2025 Creative Biolabs. All Rights Reserved.